Glacier Bancorp reports Q2 results today against a backdrop of rising short interest and options positioning that has turned notably more cautious.
Short sellers have added meaningfully to their positions. Short interest climbed 38% over the past month to 6.7% of the free float — a level that warrants attention for a mid-sized regional bank. The build has been persistent: shares short moved from roughly 6.2 million in mid-June to 8.65 million by July 22. Despite that, the borrow market remains relaxed. Availability runs at 564% — meaning more than five shares are available to borrow for every one already lent out — and the cost to borrow is just 0.49%, both consistent with a short base that is growing by conviction rather than through a squeeze-driven squeeze dynamic. The ORTEX short score of 55.2 sits in a moderate range but has edged off its recent high of 56.2.
Options traders have also shifted defensively into the print. The put/call ratio has jumped to 0.50, roughly 1.8 standard deviations above its 20-day average of 0.38 — the most hedged reading in recent months, even if still well below the 52-week high of 1.41. That shift came suddenly: the PCR sat below 0.34 for most of early-to-mid July before spiking in the days immediately preceding results. The stock itself fell 7% over the past week to $50.65, a sharper move than close peers — , , and each fell less than 1% on the week — suggesting GBCI-specific nervousness rather than a sector-wide rotation.
The bull and bear cases into today's print are well-defined. Bulls point to NIM expansion — a recent ORTEX note flagged a 22-basis-point improvement following the core system conversion, with management guiding NIM to cross 4% in the second half of 2026, supported by fixed-asset repricing and maturing CD portfolios. The analyst community remains constructive: following Q1 results in late April, both Stephens and DA Davidson raised targets (to $54 and $58 respectively), and Piper Sandler lifted its target to $60, all while maintaining positive ratings. The mean price target of $56.58 implies roughly 12% upside from current levels. Bears focus on loan growth that has lagged internal targets — Q1 came in at 2.1% against a 4.1% forecast, with CRE weakness the primary drag — and on credit quality risk if the Mountain West economy softens.
Today's Q2 report tests whether the NIM expansion story is translating into earnings momentum strong enough to justify the stock's re-rating, and whether loan growth has found a floor after a quarter that disappointed on that front.
See the live data behind this article on ORTEX.
Open GBCI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
